HCP
NARI

Hexagon Capital Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Hexagon Capital Partners’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19
Closed -$970 – 1958
2024
Q4 		$970 Buy
19
+16
+533% +$786 ﹤0.01% 1593
2024
Q3 		$124 Buy
+3
New +$144 ﹤0.01% 1527

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Hexagon Capital Partners's NARI Position: Q1 2025 in Review

Hexagon Capital Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 19 shares — an estimated $970 sold.

Hexagon Capital Partners first reported a position in NARI in Q3 2024 and held it in 2 quarters. The position peaked at $970 in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Hexagon Capital Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 19 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $970.
  • Hexagon Capital Partners first reported a position in Inari Medical, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
  • Hexagon Capital Partners's Inari Medical, Inc. Common Stock position peaked at $970 in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Hexagon Capital Partners's 13F filing for Q1 2025, filed 29 Apr 2025.